Early captopril treatment prevents hypertrophy-dependent gene expression in hearts of SHR

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 6 43-6, 1998, Pages

  Chen, Songcang ^a,c   Su, Jinzi ^a   Wu, Kegui ^b   Hu, Wenyang ^a   Gardner, David G ^a   Chen, Daguang ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atrial natriuretic peptide; Cardiac hypertrophy; Spontaneously hypertensive rat

Indexed keywords

CAPTOPRIL;

ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; DRUG EFFECT; GENE EXPRESSION; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031744427     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.6.r1511     Document Type: Article

References (25)

1. Bagby, S. P., W. J. McDonald, and R. D. Mass. Serial renin-ANG studies in spontaneously hypertensive and Wistar-Kyoto normotensive rats. Transition from normal- to high-renin status during the established phase of spontaneous hypertension. Hypertension 1: 347-354, 1979.
2. Brown, L. A., D. J. Nunez, C. I. Brookes, and M. R. Wilkins. Selective increase in endothelin-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venacaval fistula rat. Cardiovasc. Res. 29: 768-774, 1995.
3. Chien, K. R., K. U. Knowlton, H. Zhu, and S. Chien. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 5: 3037-3046, 1991.
4. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
5. Christensen, K. L., L. T. Jespersen, and M. J. Mulvany. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J. Hypertens. 7: 83-90, 1989.
6. Curran, T., M. B. Gordon, K. L. Rubino, and L. C. Sambucetti. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2: 79-84, 1987.
7. Favera, R. D., E. P. Gelmann, S. Martinotti, G. Franchini, T. S. Papas, R. C. Gallo, and F. W. Staal. Cloning and characterization of different human sequences related to the oncogene (v-myc) of avian myelocytomatosis virus (MC29). Proc. Natl.Acad. Sci. USA 79: 6497-6501, 1982.
8. Freslon, J. L., and J. F. Giudicelli. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br. J. Pharmacol. 80: 533-543, 1983.
9. Harrap, S. B., W. M. Van der Merwe, S. A. Griffin, F. Macpherson, and A. F. Lever. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 16: 603-614, 1990.
10. Ito, H., M. Hiroe, Y. Hirata, H. Fujisaki, S. Adachi, H. Akimoto, Y. A., Ohta, and F. Marumo. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation 89: 2198-2203, 1994.
11. Jackson, T., M. F. Allard, C. M. Sreenan, L. K. Doss, S. P. Bishop, and J. L. Swain. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol. Cell. Biol. 10: 3709-3716, 1990.
12. Kim, S., K. Ohta, A. Hamaguchi, T. Yukimura, K. Miura, and H. Iwao. Effects of an ATI receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats. Br. J. Pharmacol. 118: 549-556, 1996.
13. Komuro, I., M. Kurabayashi, F. Takaku, and Y. Yazaki. Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ. Res. 62: 1075-1079, 1988.
14. McDonald, W., C. Wickre, S. Aumann, D. Ban, and B. Moffitt. The sustained antihypertensive effect of chronic cerebroventricular infusion of angiotensin antagonist in spontaneously hypertensive rats. Endocrinology 107: 1305-1308, 1980.
15. Nagano, M., J. Higaki, H. Mikami, M. Nakamaru, K. Higashimori, K. Katahira, Y. Tabuchi, A. Moriguchi, F. Nakamura, and T. Ogihara. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J. Hypertens. 9: 595-599, 1991.
16. Nyborg, N. C. B., and M. J. Mulvany. Lack of effect of anti-hypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive rats. Cardiovasc. Res. 19: 528-536, 1985.
17. O'Sullivan, J. B., and S. B. Harrap. Resetting blood pressure in spontaneously hypertensive rats. Hypertension 25: 162-165 1995.
18. Owens, G. K. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 9: 178-187, 1987.
19. Sadoshima, J., Y. Xu, H. S. Slayter, and S. Izumo. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984, 1993.
20. Schunkert, H., E. O. Weinberg, G. Bruckschlegel, A. J. G. Riegger, and B. H. Lorell. Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J. Clin. Invest. 96: 2768-2774, 1995.
21. Seidman, C. E., A. D. Duby, E. Choi, R. M. Graham, E. Haber, C. Homey, J. A. Smith, and J. G. Seidman. The structure of rat preproatrial natriuretic factor as denned by a complememtary DNA clone. Science 225: 324-326, 1984.
22. Smeda, J. S., R. M. K. W. Lee, and J. B. Forrest. Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite absence of hypertension. Circ. Res. 63: 534-542, 1988.
23. Unger, T., I. Kaufman-Buhler, B. Scholkens, and D. Ganten. Brain converting enzyme inhibition: a possible mechanism .for the anti-hypertensive action of captopril in spontaneously hypertensive rats. Eur. J. Pharmacol. 70: 467-478, 1981.
24. Wahlander, H., M. Sohtell, A. Wickman, A. Nilsson, and P. Friberg. Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 27: 327-334, 1996.
25. Wu, J. N., and K. H. Berecek. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension 22: 139-146, 1993.